BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31606409)

  • 1. Clinical prospects of biomarkers for the early detection and/or prediction of organ injury associated with pharmacotherapy.
    Tajima S; Yamamoto N; Masuda S
    Biochem Pharmacol; 2019 Dec; 170():113664. PubMed ID: 31606409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Novel AKI Biomarkers after Exercise. A Systematic Review.
    Wołyniec W; Ratkowski W; Renke J; Renke M
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Relevance and Predictive Value of Damage Biomarkers of Drug-Induced Kidney Injury.
    Kane-Gill SL; Smithburger PL; Kashani K; Kellum JA; Frazee E
    Drug Saf; 2017 Nov; 40(11):1049-1074. PubMed ID: 28674842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary, Plasma, and Serum Biomarkers' Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis.
    Ho J; Tangri N; Komenda P; Kaushal A; Sood M; Brar R; Gill K; Walker S; MacDonald K; Hiebert BM; Arora RC; Rigatto C
    Am J Kidney Dis; 2015 Dec; 66(6):993-1005. PubMed ID: 26253993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of Drug-Induced Kidney Toxicity.
    Griffin BR; Faubel S; Edelstein CL
    Ther Drug Monit; 2019 Apr; 41(2):213-226. PubMed ID: 30883514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.
    Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M
    Iran J Kidney Dis; 2015 Jul; 9(4):306-10. PubMed ID: 26174458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
    Waring WS; Moonie A
    Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat Urinary Osteopontin and Neutrophil Gelatinase-Associated Lipocalin Improve Certainty of Detecting Drug-Induced Kidney Injury.
    Phillips JA; Holder DJ; Ennulat D; Gautier JC; Sauer JM; Yang Y; McDuffie E; Sonee M; Gu YZ; Troth SP; Lynch K; Hamlin D; Peters DG; Brees D; Walker EG
    Toxicol Sci; 2016 Jun; 151(2):214-23. PubMed ID: 27026710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel acute kidney injury biomarkers: their characteristics, utility and concerns.
    Beker BM; Corleto MG; Fieiras C; Musso CG
    Int Urol Nephrol; 2018 Apr; 50(4):705-713. PubMed ID: 29307055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.
    Hosohata K; Ando H; Fujimura A
    J Pharmacol Exp Ther; 2012 Jun; 341(3):656-62. PubMed ID: 22399813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury.
    Schley G; Köberle C; Manuilova E; Rutz S; Forster C; Weyand M; Formentini I; Kientsch-Engel R; Eckardt KU; Willam C
    PLoS One; 2015; 10(12):e0145042. PubMed ID: 26669323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of biomarkers in nephropharmacology.
    Khan E; Batuman V; Lertora JJ
    Biomark Med; 2010 Dec; 4(6):805-14. PubMed ID: 21133700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of renal function, which and when?
    Wasung ME; Chawla LS; Madero M
    Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers for ischemia, do we have something better then creatinine and glomerular filtration rate?
    Sprenkle P; Russo P
    Arch Esp Urol; 2013; 66(1):99-114. PubMed ID: 23406805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Update of NGAL in Acute Kidney Injury.
    Shang W; Wang Z
    Curr Protein Pept Sci; 2017; 18(12):1211-1217. PubMed ID: 27634444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the usefulness of novel biomarkers for drug-induced acute kidney injury in beagle dogs.
    Zhou X; Ma B; Lin Z; Qu Z; Huo Y; Wang J; Li B
    Toxicol Appl Pharmacol; 2014 Oct; 280(1):30-5. PubMed ID: 25034533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study.
    Jaques DA; Spahr L; Berra G; Poffet V; Lescuyer P; Gerstel E; Garin N; Martin PY; Ponte B
    Nephrology (Carlton); 2019 Feb; 24(2):170-180. PubMed ID: 29369449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers.
    Halawa A
    Ann Transplant; 2011; 16(1):90-8. PubMed ID: 21436782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.